Cargando…
P1599: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AND CONCOMITANT COVID-19 INFECTION
Autores principales: | Polyakov, Y., Kaluzhskaya, K., Baryakh, E., Gemdzhian, E., Misyurina, E., Zhelnova, E., Yatskov, K., Kochneva, O., Andreev, S., Chudnova, T., Ivanova, D., Tolstykh, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429652/ http://dx.doi.org/10.1097/01.HS9.0000849252.96108.69 |
Ejemplares similares
-
PB1870: COVID - 19 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: HOSPITAL MORALITY PREDICTORS
por: Kochneva, O., et al.
Publicado: (2022) -
PB2272: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN HEMATOLOGICAL PATIENTS WITH 4 GRADE NEUTROPENIA AND CONCOMITANT CORONAVIRUS INFECTION
por: Kaluzskaya, K., et al.
Publicado: (2022) -
P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19
por: Chudnova, T., et al.
Publicado: (2022) -
PB1853: IN-HOSPITAL SURVIVAL OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND CONCOMITANT CORONAVIRUS INFECTION DEPENDING ON VARIOUS CLINICAL FACTORS.
por: Baryakh, E., et al.
Publicado: (2022) -
P1586: IN-HOSPITAL MORTALITY AND POOR PROGNOSIS FACTORS ASSESSMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND COVID-19.
por: Ivanova, D., et al.
Publicado: (2022)